• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD/CAREFUSION 303 INC. SET ADMINISTRATION INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD/CAREFUSION 303 INC. SET ADMINISTRATION INTRAVASCULAR Back to Search Results
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 05/21/2019
Type of Reportable Event Malfunction
Event or Problem Description
Patient required blood transfusion.Three alaris modules and two sets of blood tubings failed to work properly with the "air-in-line" alarm, although there weren't bubbles apparent in the tubing.Delay of initiating transfusion, but did not negatively impact patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SET ADMINISTRATION INTRAVASCULAR
Common Device Name
SET ADMINISTRATION INTRAVASCULAR
Manufacturer (Section D)
BD/CAREFUSION 303 INC.
MDR Report Key8646084
Report NumberMW5086930
Device Sequence Number2473186
Product Code FPA
UDI-Device Identifier07613203011310
UDI-Public(01)07613203011310
Combination Product (Y/N)Y
Initial Reporter StateAK
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Voluntary
Initial Reporter Occupation Risk Manager
Type of Report Initial
Report Date (Section B) 05/23/2019
3 Devices were Involved in the Event: 1   2   3  
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device No Information
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date05/24/2019
Patient Sequence Number1
Patient Age50 YR
Patient Weight89
-
-